TY - JOUR
T1 - Erratum
T2 - Performance of ACMG-AMP Variant-Interpretation Guidelines among Nine Laboratories in the Clinical Sequencing Exploratory Research Consortium (American Journal of Human Genetics (2016) 98(6) (1067–1076) (S0002929716300593) (10.1016/j.ajhg.2016.03.024))
AU - Amendola, Laura M.
AU - Jarvik, Gail P.
AU - Leo, Michael C.
AU - McLaughlin, Heather M.
AU - Akkari, Yassmine
AU - Amaral, Michelle D.
AU - Berg, Jonathan S.
AU - Biswas, Sawona
AU - Bowling, Kevin M.
AU - Conlin, Laura K.
AU - Cooper, Greg M.
AU - Dorschner, Michael O.
AU - Dulik, Matthew C.
AU - Ghazani, Arezou A.
AU - Ghosh, Rajarshi
AU - Green, Robert C.
AU - Hart, Ragan
AU - Horton, Carrie
AU - Johnston, Jennifer J.
AU - Lebo, Matthew S.
AU - Milosavljevic, Aleksandar
AU - Ou, Jeffrey
AU - Pak, Christine M.
AU - Patel, Ronak Y.
AU - Punj, Sumit
AU - Richards, Carolyn Sue
AU - Salama, Joseph
AU - Strande, Natasha T.
AU - Yang, Yaping
AU - Plon, Sharon E.
AU - Biesecker, Leslie G.
AU - Rehm, Heidi L.
N1 - Publisher Copyright:
© 2016 American Society of Human Genetics
PY - 2016/7/7
Y1 - 2016/7/7
N2 - (The American Journal of Human Genetics 98, 1067–1076; June 2, 2016) On page 1072 in the originally published version of this article, PS2 was a typo and should have read PS3 in the following sentence: “The other most common examples of modified strength included the following: PVS1 (a predicted null variant in a gene where LOF is a known mechanism of disease) was downgraded from very strong four times, PS2 (well-established functional studies show a deleterious effect) was downgraded three times, and BS1 (MAF is too high for the disorder) was downgraded three times.” The error has been corrected online, and the authors apologize for the oversight.
AB - (The American Journal of Human Genetics 98, 1067–1076; June 2, 2016) On page 1072 in the originally published version of this article, PS2 was a typo and should have read PS3 in the following sentence: “The other most common examples of modified strength included the following: PVS1 (a predicted null variant in a gene where LOF is a known mechanism of disease) was downgraded from very strong four times, PS2 (well-established functional studies show a deleterious effect) was downgraded three times, and BS1 (MAF is too high for the disorder) was downgraded three times.” The error has been corrected online, and the authors apologize for the oversight.
UR - http://www.scopus.com/inward/record.url?scp=84989958164&partnerID=8YFLogxK
U2 - 10.1016/j.ajhg.2016.06.001
DO - 10.1016/j.ajhg.2016.06.001
M3 - Comment/debate
AN - SCOPUS:84989958164
SN - 0002-9297
VL - 99
SP - 247
JO - American journal of human genetics
JF - American journal of human genetics
IS - 1
ER -